TriSalus Life Sciences, Inc. TLSI Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s retained earnings?
- TriSalus Life Sciences, Inc. (TLSI) reported retained earnings of -$329.04M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s retained earnings changed year-over-year?
- TriSalus Life Sciences, Inc.'s retained earnings decreased by 13.5% year-over-year, from -$289.92M to -$329.04M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), TriSalus Life Sciences, Inc.'s retained earnings has grown at a 72.8% compound annual growth rate (CAGR), from -$21.49M to -$330.58M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.